Researchers have developed a drug shown to significantly extend survival time for patients with glioblastoma, the most common primary brain tumor in adults, according to results of a new trial.

With one of the largest tuberculosis (TB) outbreaks in US history, Kansas has more to worry about than its recent Super Bowl ...

TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...

A new accelerated theta-burst stimulation protocol may be a viable alternative to more intensive and costly neuromodulation ...

Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have developed a drug shown to significantly extend survival time for patients with glioblastoma, ...

An outbreak of tuberculosis, or TB—a lung disease that is often accompanied by a hacking cough—began in January 2024 in ...

In a surprise, work in mice has found that the dormant X chromosome in females can reawaken late in life and turn on genes ...

Tuberculosis remains one of the most lethal infectious diseases caused by a single pathogen. According to the latest global ...